Evidence map›Paper›PMID 29225779›Full record

ArticleF1000Research2017

Risk of solid cancer in patients with mast cell activation syndrome: Results from Germany and USA.

Gerhard J Molderings, Thomas Zienkiewicz, Jürgen Homann, Markus Menzen, Lawrence B Afrin

Abstract read
In one paragraph

Article in F1000Research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Sexual Dimorphism in Allergic and Mast Cell-Associated Diseases.Clinical reviews in allergy & immunology · 2026
    Review
  2. AllergoOncology in Review: Harnessing Allergy in the Field of Oncology to Improve Patient Outcomes.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2026
    Review
  3. Review
  4. Breast Implant Illness May Be Rooted in Mast Cell Activation: A Case-Controlled Retrospective Analysis.Annals of surgery open : perspectives of surgical history, education, and clinical approaches · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. PD-1Cancer immunology, immunotherapy : CII · 2023
    Article
  10. Review
  11. Mast cell chymase is in contact with melanoma cellsTranslational cancer research · 2022
    Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Safe administration of chemotherapy in mast cell activation syndrome.Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners · 2021
    Article
  18. Review
  19. Article
  20. Fetal-Derived Immune Cells at the Roots of Lifelong Pathophysiology.Frontiers in cell and developmental biology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Gerhard J MolderingsInstitute of Human Genetics, University Hospital of Bonn, Bonn, D-53127, Germany.ORCID https://orcid.org/0000-0002-9005-2749
Thomas ZienkiewiczInstitute of Pathology Bonn-Duisdorf, Bonn, D-53123, Germany.
Jürgen HomannDivision of Internal Medicine, Department of Gastroenterology and Diabetology, Gemeinschaftskrankenhaus Bonn, Bonn, D-53113, Germany.
Markus MenzenDivision of Internal Medicine, Department of Gastroenterology and Diabetology, Gemeinschaftskrankenhaus Bonn, Bonn, D-53113, Germany.
Lawrence B AfrinArmonk Integrative Medicine, Armonk, NY, 10504, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

breast cancercancercervical carcinomamast cellmelanomasystemic mast cell activation diseasesystemic mast cell activation syndromesystemic mastocytosis

Identifiers

PMID29225779
PMCPMC5710302

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.